An exploratory study suggested that VitD supplementation improved 28 joint disease activity scores based on C-reactive protein (DAS28 (CRP)) in patients without VitD deficiency but did not affect patients with VitD deficiency at baseline (14). The gene discussed is CRP; the disease is arthropathy.